- Vascular-promoting therapy reduced tumor growth and progression by improving chemotherapy efficacy.
Vascular-promoting therapy reduced tumor growth and progression by improving chemotherapy efficacy.
Cancer cell (2015-01-15)
Esther Bridges, Adrian L Harris
PMID25584889
ABSTRACT
In this issue of Cancer Cell, Wong and colleagues describe a novel approach of increasing the number of functional blood vessels in tumors using a low-dose therapy regimen of Cilengtide and Verapamil. This method enhanced gemcitabine delivery, uptake, and metabolism within tumor cells to reduce tumor growth and progression.
MATERIALS
Product Number
Brand
Product Description
Supelco
(±)-Verapamil hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Verapamil hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Verapamil hydrochloride, European Pharmacopoeia (EP) Reference Standard